<DOC>
	<DOC>NCT02080104</DOC>
	<brief_summary>Intramuscular versus intravenous prophylactic oxytocin for the third stage of labour following vaginal delivery: A randomised controlled trial</brief_summary>
	<brief_title>Intramuscular Versus Intravenous Prophylactic Oxytocin for Hemorrhage After Vaginal Delivery</brief_title>
	<detailed_description>Prevention of postpartum haemorrhage is essential in the pursuit of improved health care for women. In this study investigators aimed to compare intramuscular oxytocin with intravenous oxytocin for the routine prevention of postpartum haemorrhage in women who deliver vaginally.In some countries, intravenous access can not be provided easily . Intramuscular application is faster , easier and tougher enforcement requires less skill and equipment . For this reason, less educated , which can be applied by those offering health services .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>1. Research volunteers, the undersigned, pregnant women 2. Only with vaginal delivery (episiotomy and perineal tears can) 3. &gt; 34 weeks or more will be 4. Cephalic presentation will be 5. At low risk of postpartum hemorrhage 1. &lt;18 years 2. Multiple pregnancies 3. The presence of uterine myoma 4. Having postpartum hemorrhage in previous pregnancies 5. Placenta previa, polyhydramnios 6. More than four parity 7. Fetal macrosomia 8. Hb &lt;9mg/dl 9. preeclampsia 10. Uterine anomalies 11. Receiving anticoagulant therapy, suspected coagulopathy 12. &gt; 42 weeks of pregnancy 13. Oxytocin allergy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>postpartum hemorrhage</keyword>
	<keyword>oxytocin</keyword>
	<keyword>vaginal delivery</keyword>
	<keyword>prophylactic</keyword>
</DOC>